Validation and Establishment of the SARS-CoV-2 Lentivirus Surrogate Neutralization Assay as a Prescreening Tool for the Plaque Reduction Neutralization Test-Reference-Cited by-同舟云学术

Validation and Establishment of the SARS-CoV-2 Lentivirus Surrogate Neutralization Assay as a Prescreening Tool for the Plaque Reduction Neutralization Test

Published:2023-02-14 Issue:1 Volume:11 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Merluza John¹,Ung Johnny¹,Makowski Kai¹,Robinson Alyssia¹,Manguiat Kathy¹,Mueller Nicole¹,Audet Jonathan¹,Chen Julie Chih-Yu¹²,Strong James E.¹³⁴^ORCID,Wood Heidi¹,Bello Alexander¹^ORCID

Affiliation:

1. Public Health Agency of Canada, National Microbiology Laboratory, Winnipeg, Manitoba, Canada

2. Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada

3. Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Manitoba, Canada

4. Department of Medical Microbiology & Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada

Abstract

Neutralization studies play an important role in providing guidance and justification for vaccine administration and helping prevent the spread of diseases. The neutralization data generated in our laboratory have been included in the decision-making process of the National Advisory Committee on Immunization (NACI) in Canada.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.03789-22

Reference42 articles.

1. Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings

2. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

3. Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States

4. SARS-CoV-2 Variants and Vaccination

5. SARS-CoV-2 variants, spike mutations and immune escape

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical validation of an RSV neutralization assay and testing of cross-sectional sera pre- and post- RSV outbreaks from 2021-2023;2024-06-14

2. tANCHOR-cell-based assay for monitoring of SARS-CoV-2 neutralizing antibodies rapidly adaptive to various receptor-binding domains;iScience;2024-03

3. High-Content Imaging-Based Assay for SARS-CoV-2-Neutralizing Antibodies;Vaccines;2024-02-24

4. Plaque Reduction Neutralization Test (PRNT) Accuracy in Evaluating Humoral Immune Response to SARS-CoV-2;Diseases;2024-01-18

5. Direct enhancement of viral neutralising antibody potency by the complement system: a largely forgotten phenomenon;Cellular and Molecular Life Sciences;2024-01-11